)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
AFT Pharmaceuticals Limited
AFT Pharmaceuticals Limited (AFT) investor relations material
AFT Pharmaceuticals Limited AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary30 Jul, 2026
Opening remarks and agenda
Meeting opened with a welcome, safety instructions, and introductions of directors, auditors, lawyers, and senior management, including the new CFO.
Quorum confirmed and agenda outlined, including presentations, formal business, and Q&A opportunities.
Chair and Managing Director delivered opening addresses, followed by discussion, resolutions, general business, and meeting close.
Financial performance review
Achieved record results with 22% revenue growth to NZD 254.7 million and operating profit up 39% to NZD 24.4 million, exceeding guidance.
Net profit after tax rose to NZD 14.1 million; products now sold in 87 countries.
Group revenue and profit growth driven by strong performance in Australia (revenue up 19%), New Zealand (revenue up 11%), Asia (revenue up 41%), and international markets (revenue up 66%).
Revenue per employee outperformed global peers; 17% CAGR over two decades.
Net debt increased to NZD 38.6 million, reflecting higher inventory and new product licenses, but remains within target range.
Forecasting NZD 300 million+ revenue and NZD 28–32 million operating profit for FY 2027.
Board and executive committee updates
Marree Atkinson retired by rotation and offered herself for re-election, with unanimous board support.
Malcolm Tubby, previous CFO, retired; Stuart Houliston welcomed as new CFO.
Chair David Flacks announced intention to retire within 12 months, assisting with transition.
Board includes Managing Director/CEO, Executive Director/Chief of Staff, and three Independent Directors.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from AFT Pharmaceuticals Limited
- On track for $300M FY27 revenue, driven by strong sales, R&D, and global product launches.AFT
Trading update - Record 22% revenue growth and profit, with FY27 revenue targeted above $300M.AFTH2 2026
- Revenue up 33% to $114.9M, net profit $2.7M, FY26 profit guidance reaffirmed.AFTH1 2026
- Record FY25 revenue, global expansion, and higher dividends amid board changes.AFTAGM 2025
- Maxigesic IV launches in Canada as R&D and global licensing initiatives accelerate.AFTTrading Update
- Revenue up 4% to $86.7m; strong Australasian growth offsets global headwinds, FY25 profit guidance cut.AFTH1 2025
- Record growth, global expansion, and robust R&D pipeline drive positive outlook.AFTAGM 2024
- Record NZD 208M revenue and strong Australasian growth drive positive FY26 outlook.AFTH2 2025
Next AFT Pharmaceuticals Limited earnings date
H1 202718 Nov, 2026
AFT Pharmaceuticals Limited
Next AFT Pharmaceuticals Limited earnings date
H1 202718 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
AFT Pharmaceuticals Limited is a New Zealand-based pharmaceutical company that develops, licenses, and distributes a range of pharmaceutical products across Australasia and other international markets. The company’s portfolio includes over-the-counter medicines, prescription drugs, and specialty products, with a focus on pain management, allergy relief, and respiratory health. AFT Pharmaceuticals combines in-house research and development with strategic partnerships to bring innovative treatments to market, aiming to address unmet medical needs and improve patient outcomes. The company is headquartered in Auckland, New Zealand, and its shares are listed on the NZX and ASX.